A detailed history of Acadian Asset Management LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Acadian Asset Management LLC holds 2,078,287 shares of ACRS stock, worth $7.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,078,287
Previous 1,913,449 8.61%
Holding current value
$7.9 Million
Previous $2.1 Million 13.55%
% of portfolio
0.01%
Previous 0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$1.12 - $1.4 $184,618 - $230,773
164,838 Added 8.61%
2,078,287 $2.39 Million
Q2 2024

Aug 06, 2024

SELL
$1.01 - $1.36 $224,137 - $301,808
-221,918 Reduced 10.39%
1,913,449 $2.1 Million
Q1 2024

May 10, 2024

SELL
$0.92 - $1.44 $198,756 - $311,097
-216,040 Reduced 9.19%
2,135,367 $2.65 Million
Q4 2023

Feb 13, 2024

BUY
$0.64 - $6.49 $1.5 Million - $15.3 Million
2,351,407 New
2,351,407 $2.47 Million
Q1 2021

May 11, 2021

SELL
$5.86 - $27.73 $500,221 - $2.37 Million
-85,362 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$2.65 - $7.61 $288,410 - $828,226
-108,834 Reduced 56.04%
85,362 $551,000
Q3 2020

Nov 09, 2020

BUY
$1.5 - $2.71 $149,044 - $269,273
99,363 Added 104.78%
194,196 $499,000
Q2 2020

Aug 12, 2020

BUY
$1.04 - $1.73 $79,750 - $132,661
76,683 Added 422.5%
94,833 $153,000
Q1 2020

May 11, 2020

BUY
$0.75 - $2.18 $13,612 - $39,567
18,150 New
18,150 $19,000
Q4 2019

Feb 06, 2020

SELL
$1.02 - $1.97 $242,998 - $469,320
-238,234 Closed
0 $0
Q3 2019

Nov 07, 2019

BUY
$0.79 - $2.47 $188,204 - $588,437
238,234 New
238,234 $257,000

Others Institutions Holding ACRS

About Aclaris Therapeutics, Inc.


  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $253M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.